Digest Network Come funziona
Network
/
Società
En
Non verificato

Enveric Biosciences

Di cosa scriviamo

BiotecnologiaFarmaceuticaPsichiatriaSaluteSanità

44 comunicati stampa

Guarda tutti i comunicati
04/12/2025
Psichiatria
Scienza
Medicina - Varie
Biotecnologia
Salute
Farmaceutica
Sanità
Eventi
Enveric Biosciences to Present at and Participate in Panel Discussion at Sachs Associates 9th Annual Neuroscience Innovation Forum During “J.P. Morgan Week 2026”
Fonte
Enveric Biosciences
Emittente
Business Wire
1.00
0
26/11/2025
Biotecnologia
Sanità
Psichiatria
Salute
Farmaceutica
Enveric Biosciences Receives Fourth Notice of Allowance for EVM401 Series of Drug Candidates
Fonte
Enveric Biosciences
Emittente
Business Wire
1.00
0
14/11/2025
Biotecnologia
Sanità
Salute
Psichiatria
Mercato azionario
Enveric Biosciences Reports Third Quarter 2025 Financial and Corporate Results
Fonte
Enveric Biosciences
Emittente
Business Wire
1.00
0
23/10/2025
Biotecnologia
Sanità
Psichiatria
Salute
Finanza
Enveric Biosciences Announces Reverse Stock Split
Fonte
Enveric Biosciences
Emittente
Business Wire
1.00
0
16/10/2025
Scienza
Biotecnologia
Farmaceutica
Salute
Psichiatria
Enveric Biosciences Further Enhances Intellectual Property Estate with New U.S. Patent Issuance
Fonte
Enveric Biosciences
Emittente
Business Wire
1.00
0
15/10/2025
Biotecnologia
Salute
Farmaceutica
Medicina - Varie
Legge/Diritto
Industria
Enveric Biosciences Hires IP Powerhouse to Defend Its U.S. Patent with Claims Relevant to Bretisilocin, Recently Acquired by AbbVie in $1.2 Billion Deal
Fonte
Enveric Biosciences
Emittente
Business Wire
1.00
0
14/10/2025
Psichiatria
Salute
Tecnica
Biotecnologia
Industria
Enveric Biosciences to Explore Digital Asset Treasury Opportunities
Fonte
Enveric Biosciences
Emittente
Business Wire
1.00
0
02/10/2025
Psichiatria
Scienza
Medicina - Varie
Biotecnologia
Salute
Farmaceutica
Sanità
Industria
Enveric Biosciences Successfully Completes Key Manufacturing Milestones in Support of Planned IND and Clinical Trials
Fonte
Enveric Biosciences
Emittente
Business Wire
1.00
0
17/09/2025
Psichiatria
Salute
Sanità
Farmaceutica
Biotecnologia
Industria
Enveric Biosciences Announces Publication of Two Peer-Reviewed Articles Highlighting Novel Bioproduction Methods for Neuropsychiatric Drug Discovery
Fonte
Enveric Biosciences
Emittente
Business Wire
1.00
0
16/09/2025
Psichiatria
Scienza
Igiene alimentare
Biotecnologia
Salute
Farmaceutica
Industria
Enveric Biosciences Receives FDA Response and Streamlines Plans for EB-003 IND Submission
Fonte
Enveric Biosciences
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0